IL1RN, interleukin 1 receptor antagonist, 3557

N. diseases: 701; N. variants: 52
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0152021
Disease: Congenital heart disease
Congenital heart disease
0.010 Biomarker group BEFREE The importance of the anti-inflammatory mediators IL-1ra and IL-10, as well as cytokines Epo and VEGF, which could impact on the pathogenesis and outcomes in congenital heart disease (CHD) which is more prevalent in DS, are less well known. 31785499 2020
CUI: C0270850
Disease: Idiopathic generalized epilepsy
Idiopathic generalized epilepsy
0.010 GeneticVariation disease BEFREE <b>Background:</b> Neuroinflammation is an important feature of epileptogenesis.<b>Objectives:</b> To investigate the association of Interleukin-1beta-31 (IL-1β-31) and Interleukin-1 receptor antagonist (IL1-RA) genetic polymorphisms with idiopathic generalized epilepsy and demonstrate their influence on drug resistance in children.<b>Materials and Methods:</b> One hundred children with idiopathic generalized epilepsy were age and gender-matched with apparently healthy controls. 31698971 2020
CUI: C0751057
Disease: Seizure, Febrile, Complex
Seizure, Febrile, Complex
0.010 AlteredExpression disease BEFREE Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. 31709864 2020
CUI: C1306587
Disease: Acute encephalopathy
Acute encephalopathy
0.010 AlteredExpression disease BEFREE Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. 31709864 2020
Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site
0.010 GeneticVariation disease BEFREE The high-risk tumors overexpressed IL23A and IL1RN genes and enriched with cancer-related bacteria (Bacteroides fragilis,Peptostreptococcus, Parvimonas, Alloprevotella and Gemella) compared to the low-risk tumors. 31693169 2020
CUI: C3495798
Disease: Periodontal inflammation
Periodontal inflammation
0.010 Biomarker disease BEFREE Preparation and Evaluation of IL-1ra-Loaded Dextran/PLGA Microspheres for Inhibiting Periodontal Inflammation In Vitro. 31664694 2020
Secondary haemophagocytic lymphohistiocytosis
0.010 Biomarker disease BEFREE To assess the benefit of the recombinant human interleukin-1 receptor antagonist, anakinra, in treating pediatric patients with secondary hemophagocytic lymphohistiocytosis (sHLH) / macrophage activation syndrome (MAS) associated with rheumatologic and non-rheumatologic conditions. 31513353 2020
CUI: C0001486
Disease: Adenovirus Infections
Adenovirus Infections
0.010 Biomarker group BEFREE Responses of several cytokines such as IL-1RA, IL-21 and all of the chemokines were found after adenovirus infection. 30217569 2019
CUI: C0001815
Disease: Primary Myelofibrosis
Primary Myelofibrosis
0.010 Biomarker disease BEFREE These findings suggest that both SLAMF7<sup>high</sup> monocytes and IL-1ra could be useful noninvasive markers of MF onset. 31270105 2019
CUI: C0003486
Disease: Aortic Aneurysm
Aortic Aneurysm
0.010 AlteredExpression disease BEFREE In addition, BM-MSCs and MSCs-CM reduced MCP-1, IL-1Ra and IL-6 expression and increased IL-10 expression in AA tissues. 31583844 2019
CUI: C0008055
Disease: Chikungunya Fever
Chikungunya Fever
0.010 Biomarker disease BEFREE The results also revealed a higher production of IL-1 RN protein in patients with chronic chikungunya. 31294845 2019
CUI: C0011334
Disease: Dental caries
Dental caries
0.010 Biomarker disease BEFREE No significant difference was found in the alleles and genotypes of five genes ( ENAM, TUFT1, MMP13, IL10 and IL1RN) between those with and without dental caries. 30803280 2019
CUI: C0017638
Disease: Glioma
Glioma
0.010 Biomarker disease BEFREE Here we demonstrated that methionine deprivation inhibited glioma cell proliferation via downregulating interleukin 1 receptor antagonist (IL1RN) both in vitro and in vivo, methionine deprivation or knocking down IL1RN induced glioma cell cycle arrest. 30978442 2019
CUI: C0023283
Disease: Leishmaniasis, Cutaneous
Leishmaniasis, Cutaneous
0.010 GeneticVariation disease BEFREE The SNPs -511T/C (rs16944) and +3954C/T (rs1143634) of the IL1B and IL1RN VNTR (rs2234663) were assessed in 881 patients with CL and 837 healthy controls by PCR-RFLP and direct PCR respectively. 31357078 2019
CUI: C0026946
Disease: Mycoses
Mycoses
0.010 Biomarker group BEFREE Administration of human recombinant IL-1RA (Kineret/anakinra) during fungal-associated allergic airway inflammation improved airway hyperreactivity and lowered type 1 and type 17 responses. 31550242 2019
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis
0.010 Biomarker disease BEFREE These findings suggest that both SLAMF7<sup>high</sup> monocytes and IL-1ra could be useful noninvasive markers of MF onset. 31270105 2019
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 Biomarker phenotype BEFREE A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. 29845881 2019
CUI: C0030805
Disease: Bullous pemphigoid
Bullous pemphigoid
0.010 Biomarker disease BEFREE We demonstrated that several markers related to the alternatively activated macrophage phenotype (M2) including IL-10, TARC, arginase, TNFα, and IL-1RA were meaningfully increased in BF of patients with BP. 31440247 2019
CUI: C0031117
Disease: Peripheral Neuropathy
Peripheral Neuropathy
0.010 Biomarker group BEFREE IL-1RA transiently abolishes allodynia in PAE rats, suggesting that IL-1β is in part, necessary for the susceptibility of adult-onset peripheral neuropathy caused by PAE. 30961664 2019
CUI: C0040264
Disease: Tinnitus
Tinnitus
0.010 Biomarker phenotype BEFREE Moreover, this issue addresses how oral hygiene is a concern for the entire organism, that younger age goes well with neoadjuvant chemotherapy for breast cancer and zinc with feeling less distressed by tinnitus caused by noise-induced hearing loss, and that IL-1Ra holds very promising potential to prevent intestinal ischemia reperfusion injury. 30987700 2019
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.010 GeneticVariation disease BEFREE The minor allele T and the genotype TT of SNP rs1800794 in IL1A as well as the genotype 1A3A of IL1RN rs2234663 VNTR seem to increase the risk of getting Trypanosoma brucei gambiense infections and develop sleeping sickness in southern Cameroon. 30908482 2019
CUI: C0042029
Disease: Urinary tract infection
Urinary tract infection
0.010 Biomarker group BEFREE However, the effects of IL-1R antagonist (IL-1RA) on immune responses during UTI, except for its ability to disrupt IL-1β signalling, are not well understood. 31299415 2019
CUI: C0085612
Disease: Ventricular arrhythmia
Ventricular arrhythmia
0.010 Biomarker disease BEFREE Moreover, treatment of I/R-WT mice with IL-1r antagonist (IL-1ra) from 8 to 15 days post perfusion did not interfere with renal function, but reversed QJ prolongation, prevented the increase in susceptibility to ventricular arrhythmias and rescued a close to normal duration and amplitude of calcium transient. 31029578 2019
CUI: C0149896
Disease: Primary gout
Primary gout
0.010 GeneticVariation disease BEFREE In this retrospective observational study, we assess the efficacy and safety of the interleukin 1 receptor antagonist anakinra in medically complex, hospitalized patients with acute gout and calcium pyrophosphate crystal arthritis. 30647192 2019
CUI: C0151779
Disease: Cutaneous Melanoma
Cutaneous Melanoma
0.010 GeneticVariation disease BEFREE Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma. 31788049 2019